Skip to content
A Scorecard to Improve Drugmakers’ Transparency episode artwork

Nov 25, 2015 19 min

A Scorecard to Improve Drugmakers’ Transparency

from The Bio Report Hosted by Levine Media Group

A large number of clinical trials underlying the approval of drugs never come into public view. This not only has legal and ethical ramifications, but implications for the healthcare system as a whole. We spoke to Jennifer Miller, founding president of Bioethics International and assistant professor at the NYU School of Medicine about her recent study in BMJ Open, part of an effort to improve transparency through the creation of a Good Pharma Scorecard. Miller discussed the study, the scorecard, and the state of transparency in the pharmaceutical industry.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

A Scorecard to Improve Drugmakers’ Transparency

0:00 19:44

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The Bio Report?

This episode is 19 minutes long.

When was this The Bio Report episode published?

This episode was published on November 25, 2015.

Can I download this The Bio Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.